Catherine Van Der Kar is a notable inventor based in Grand Prairie, TX (US). She has made significant contributions to the field of biomedical engineering, particularly in the area of bacterial biofilm reduction. With a total of 2 patents, her work has the potential to impact various medical applications.

Latest Patents

Catherine's latest patents include innovative methods for addressing bacterial biofilms. One patent focuses on the "Use of thermolysin to reduce or eliminate bacterial biofilms from surfaces." This method discloses techniques for treating wounds, skin lesions, and other biological surfaces infected with bacterial biofilms using compositions that contain thermolysin. Another patent is titled "Use of seaprose to remove bacterial biofilm." This method involves applying a semi-alkaline protease produced by the fermentation of the fungus Seaprose to disrupt the matrix of bacterial biofilms on surfaces.

Career Highlights

Catherine is currently employed at Smith + Nephew, a company known for its advanced medical technologies. Her work at this organization allows her to apply her innovative ideas in practical settings, contributing to the development of effective solutions for healthcare challenges.

Collaborations

Catherine has collaborated with talented coworkers, including Lei Shi and Aleksa Jovanovic. These partnerships enhance her research and development efforts, fostering a collaborative environment that drives innovation.

Conclusion

Catherine Van Der Kar's contributions to the field of biomedical engineering through her patents demonstrate her commitment to improving healthcare solutions. Her innovative approaches to bacterial biofilm reduction are paving the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.